Nuvation Bio Inc - Ordinary Shares - Class A Forecast, price target & analysts
Nuvation Bio Inc - Ordinary Shares - Class A Target price 2025 - Analyst rating & recommendation
Nuvation Bio Inc - Ordinary Shares - Class A Classifications & Recommendation:
Nuvation Bio Inc - Ordinary Shares - Class A Price Target
| Target Price | $10.20 |
| Price | $8.31 |
| Potential |
22.74%
register free of charge
|
| Number of Estimates | 9 |
|
9 Analysts have issued a price target Nuvation Bio Inc - Ordinary Shares - Class A 2026 .
The average Nuvation Bio Inc - Ordinary Shares - Class A target price is $10.20.
This is
22.74%
register free of charge
$12.60
51.62%
register free of charge
$7.07
14.92%
register free of charge
|
|
| A rating was issued by 14 analysts: 13 Analysts recommend Nuvation Bio Inc - Ordinary Shares - Class A to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Nuvation Bio Inc - Ordinary Shares - Class A stock has an average upside potential 2026 of
22.74%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 7.87 | 30.17 |
| 283.32% | ||
| Net Margin | -7,216.52% | -757.22% |
| 89.51% |
10 Analysts have issued a sales forecast Nuvation Bio Inc - Ordinary Shares - Class A 2025 . The average Nuvation Bio Inc - Ordinary Shares - Class A sales estimate is
This results in the following potential growth metrics:
10 Nuvation Bio Inc - Ordinary Shares - Class A Analysts have issued a net profit forecast 2025. The average Nuvation Bio Inc - Ordinary Shares - Class A net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -2.11 | -0.67 |
| 502.86% | 68.25% | |
| P/E | negative | |
| EV/Sales | 83.94 |
10 Analysts have issued a Nuvation Bio Inc - Ordinary Shares - Class A forecast for earnings per share. The average Nuvation Bio Inc - Ordinary Shares - Class A EPS is
This results in the following potential growth metrics and future valuations:
Nuvation Bio Inc - Ordinary Shares - Class A...
Current Nuvation Bio Inc - Ordinary Shares - Class A Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Dec 01 2025 |
| Truist Securities |
Locked
➜
Locked
|
Locked | Nov 24 2025 |
| Citizens |
Locked
➜
Locked
|
Locked | Nov 20 2025 |
| B. Riley Securities |
Locked
➜
Locked
|
Locked | Nov 19 2025 |
| Citizens |
Locked
➜
Locked
|
Locked | Nov 04 2025 |
| RBC Capital |
Locked
➜
Locked
|
Locked | Nov 04 2025 |
| Wedbush |
Locked
➜
Locked
|
Locked | Oct 13 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Dec 01 2025 |
|
Locked
Truist Securities:
Locked
➜
Locked
|
Nov 24 2025 |
|
Locked
Citizens:
Locked
➜
Locked
|
Nov 20 2025 |
|
Locked
B. Riley Securities:
Locked
➜
Locked
|
Nov 19 2025 |
|
Locked
Citizens:
Locked
➜
Locked
|
Nov 04 2025 |
|
Locked
RBC Capital:
Locked
➜
Locked
|
Nov 04 2025 |
|
Locked
Wedbush:
Locked
➜
Locked
|
Oct 13 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
